Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes

15.12.2017

V časopise ClinicoEconomics and Outcomes Research vyšiel článok:

Psota M, Psenkova MB, Racekova N, Ramirez de Arellano A, Vandebrouck T, Hunt B.:

Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system.

Článok je možné stiahnuť tu: https://www.dovepress.com/cost-effectiveness-analysis-of-ideglira-versus-basal-bolus-insulin-for-peer-reviewed-article-CEOR

Späť